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Aim of this commentary is to summarize the salient literature news on the relationships between autoimmune thyroid
diseases (ATDs) and either Down syndrome (DS) or Turner syndrome (TS).
According to literature reports both Hashimoto’s thyroiditis (HT) and Graves’ disease (GD) are more frequent in children
with DS or TS than in those without these chromosomopathies.
An up-regulation of proinflammatory cytokines might be responsible for the enhanced susceptibility of TS children to
ATDs, whereas a dysregulation of immune system may favor the development of ATDs in DS.
In TS children biochemical presentation of HT is less severe than in peer controls. In both DS and TS GD picture at the
time of diagnosis is not significantly different than in the pediatric general population.
The evolution over time of GD in DS and TS does not differ from that observed in the pediatric general population,
whereas the evolution of HT in both TS and DS is more severe than in girls without these chromosomopathies.
Conclusions: The association with TS or DS is able to affect both epidemiology and course of ATDs by conditioning: a) an
increased susceptibility to these disorders; b) a less severe biochemical presentation and a more severe evolutive pattern
of HT in TS girls; c) a more severe biochemical presentation and evolution of HT in DS patients.
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Hashimoto’s thyroiditis (HT) and Graves’ disease (GD) are
organ-specific autoimmune disorders, that are more com-
mon in girls than in boys. In both sexes their frequency
increases with age, peaking during adolescence. These
autoimmune thyroid diseases (ATDs) occur more fre-
quently in genetically susceptible children, as suggested by
the higher concordance in monozygotic than dizygotic
twins [1, 2], but their occurrence is also conditioned by
environmental triggers, such as iodine intake [3–6].
Other important risk factors for ATDs are familial ante-
cedents of autoimmune disorders, links with other extra-
thyroidal autoimmune diseases and association with either
Turner syndrome (TS) or Down syndrome (DS), i.e. two
common chromosomopathies which are known to be fre-
quently linked with autoimmune illnesses [7, 8].* Correspondence: filippo.deluca@unime.it
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unless otherwise stated.According to the most recent literature reports, ATDs
in children with either TS or DS seem to be characterized
by some significant peculiarities in terms of epidemiology,
pathophysiology and clinical course. These reports seem
to suggest that the association with these chromosomopa-
thies might condition peculiar phenotypical expressions of
ATDs [9–14].
Aim of this commentary is to summarize the salient lit-
erature news concerning the relationships between ATDs
and both these chromosomopathies.Epidemiology
In pediatric age HT is a relatively common disease, whose
prevalence has been estimated to fluctuate around 1.2 %
[15, 16] and is distinctly higher than that reported for GD
in the same age bracket, i.e. 1‰ [17] (Table 1).
In TS girls HT is by far the most common autoimmune
disorder and its prevalence has been reported to be even
higher than that generally reported in age-matched girlsThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0) which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Prevalence rates of Hashimoto’s thyroiditis (HT) and
Graves’ disease (GD) in the pediatric general population and in





HT 1.2–1.3 % [15, 16]a 10–21 % [14, 18–20, 23, 24]a 13–34 % [25, 26]a
GD 1.07‰ [17]a 1.7–3 % [14, 21–23]a 6.5‰ [11]a
aaccording to the present reference list
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has been repeatedly reported to be distinctly higher in TS
girls (from 1.7 to 3.0 %) than in the pediatric general
population [13, 14, 21, 22]. Nevertheless, it is very far from
that of HT in TS, which is generally reported to range
from 10 to 21 % [14, 22, 23] (Table 1).
Also in DS children the prevalence rates of both HT
(13–34 %) [24, 25] and GD (6.5‰) [11] are known to
be distinctly higher than in the pediatric general popu-
lation (Table 1).
On overall, on the basis of literature reports, it may be
pointed out that both HT and GD are more frequent in
the young patients with either TS or DS than in those
without these chromosomopathies (Table 1).
Pathophysiological interpretation of these
epidemiological findings
Although it is well assessed, on the basis of the above
epidemiological reports, that young patients with TS and
DS are more prone to develop ATDs, the pathophysio-
logical mechanisms of these links have not been com-
pletely elucidated to date. Nevertheless, in the case of
TS children, this association might be, at least partially,
explained in the light of the generally recognized links
between thyroid autoimmunity and female gender [14].
Another likely and very simple explanation might be that
many pediatricians are aware that both TS and DS
children are more incline to the risk of developing ATDs
and also other autoimmune extra-thyroidal disorders,
such as celiac disease, type 1 diabetes, vitiligo and juven-
ile idiopathic arthritis [19, 26]. Consequently, HT and
GD in these conditions might be sometimes suspected
by pediatricians even in the presence of minimal thyroid
dysfunction symptoms and/or signs [10] and the finding
of a thyroid enlargement in these children might be
probably considered with more attention. Such an ex-
planation seems to be supported by the observation that
ATDs in DS children are generally diagnosed at a youn-
ger age than in those without DS [11, 12, 27].
In TS it has been hypothesized that the increased sus-
ceptibility to ATDs might be associated with haploinsuf-
ficiency of the genes in the pseudoautosomal region of
the X-chromosome [26, 28], that may play a relevantpart in the pathogenesis of autoimmune diseases [23].
According to other reports, the risk of ATDs is
especially high in the patients with X-isochromosome
[14, 29, 30], thus suggesting that a gene on the long arm
of X-chromosome might be involved in conditioning the
predisposition towards ATDs [30]. Other authors, in
contrast, have not reported any significant relationships
between ATDs and a specific karyotype [13, 22, 31, 32].
Therefore, in the light of the conflicting literature data,
no definitive conclusions can be drawn about the influ-
ence of karyotype on thyroid autoimmunity in TS.
Other features of TS phenotype, such as an up-regulation
of proinflammatory cytokines, might be, at least partially,
responsible for the enhanced susceptibility of TS patients to
ATDs [33].
In DS the increased prevalence of ATDs has been re-
cently attributed to a dysregulation of immune system
[34], with consequent defect of inhibitory activity. These
alterations may favor the development of ATDs and other
autoimmune disorders [35].
Clinical and biochemical presentation
Although there are in pediatric literature several studies
on the relationships between either TS or DS and ATDs,
only few of them have specifically addressed the intri-
guing issue whether the association with these chromo-
somal aberrations may in any way condition a different
presentation mode of ATDs in pediatric age.
A very peculiar anamnestic feature of GD in both TS
and DS children is that its presentation in these conditions
is often (20 % of cases) preceded by HT antecedents [9]. It
had been already demonstrated that, even in the pediatric
general population, there exists a continuum between HT
and GD within the spectrum of ATDs [36–40]. The spe-
cific observation that children with TS or DS are more
likely to progress from HT to GD suggests that the associ-
ation with these chromosomopathies might favor such a
metamorphosis [9].
In DS patients GD does not demonstrate any gender
predominance, as against as generally observed in the pa-
tients without DS [12]. This finding confirms that children
with DS are per se more exposed to the risk of developing
GD, irrespective of other concomitant risk factors [12].
In both these chromosomopathies clinical and bio-
chemical picture of GD at the time of diagnosis is not
significantly different from that observed in the pediatric
general population [12, 13].
In DS children the most common biochemical pat-
terns at HT presentation are subclinical hypothyroidism
(SH) and overt hypothyroidism, whereas euthyroidism is
distinctly less common than in HT children without DS
[41]. In contrast, according to a very recent study, thyroid
function impairment at HT presentation seems to be sig-
nificantly less severe than in girls without TS [10], as
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the lower prevalence rates of both overt hypothyroidism
and hyperthyroidism (Table 2). Moreover, in TS girls me-
dian TSH serum levels were reported to be significantly
lower than in sex-matched peer controls [10]. The less se-
vere impairment of thyroid function at HT presentation in
TS children might be explained on the basis of a less ag-
gressive autoimmune pattern [10].
Table 2 summarizes the prevalence rates of the different
thyroid function patterns by us detected at HT presenta-
tion in children with TS and DS and in age-matched chil-
dren without these chromosomopathies.Clinical and biochemical evolution over time
Clinical and biochemical evolution under methimazole
therapy has been specifically investigated in two studies
aiming at ascertaining whether GD children with either DS
or TS may exhibit different responses to pharmacological
therapy, with respect to young patients without these chro-
mosomopathies [12, 13].
In DS patients the course of GD under methimazole
treatment seems to be less severe than in the children with-
out DS [12]. This inference, however, is in contrast with the
results of another study on the same issue, according to
which the remission rates under pharmacological therapy
are very low in DS-related GD and many DS patients with
GD may need radioiodine ablation [11].
In TS children both the initial methimazole doses and
those needed to maintain euthyroidism during the first
treatment cycle were not different than in girls without TS
[13]. Also remission rates during the first methimazole
cycle, relapse rates after the first cycle withdrawal and cu-
mulative incidences of relapse were reported to not differ
than in GD girls without TS. Finally, even the rates of girls
who need a non-pharmacological treatment, such as sur-
gery or radioiodine ablation, do not seem to be significantly
higher in GD girls with TS [13]. Therefore, according to the
only available study aiming at comparing clinical and bio-
chemical responses to therapy in two different series of GD
girls with or without TS [13], it may be argued that the evo-
lution over time of GD does not significantly differ in the
children with TS than in those without TS.Table 2 Prevalence rates (%) of the different thyroid function patter
general population and in children with Turner syndrome (TS) or Do
Euthyroidism Subclinical hy
Pediatric general populationa 54.3 17.2
TSb 73.3 23.4
DSc 13.7 63.0
areference no. [37] of the present list
breference no. [10] of the present list
creference no. [41] of the present listThe spontaneous evolution over time of thyroid function
tests in TS children with HT has been only occasionally
evaluated so far [10, 14]. According to these reports, such
course seems to be characterized by a spontaneous deteri-
oration of thyroid function [13, 14]. In fact, thyroid tests
were reported to significantly worsen over time, both in the
girls who had presented with euthyroidism and in the ones
who had presented with thyroid dysfunctions and this
spontaneous trend seems to be irrespective of both karyo-
type and other factors [10]. Thyroid function deterioration
over time seems to be especially evident in the TS girls with
initial SH [10]. These findings are particularly striking con-
sidering that the natural history of SH in the pediatric
population had been so far reported to be generally charac-
terized by a less negative spontaneous trend, both in the
cases with an idiopathic form [42–47] and in the ones with
an underlying HT [10, 48–50]. To sum up, in the light of
these peculiarities which seem to characterize the natural
history of TS-related HT, a strict monitoring of thyroid
function has to be strongly suggested in these patients [10].
A close monitoring of thyroid tests during follow-up has
probably to be suggested also in the children with DS-
related HT, at least according to the results of a very recent
follow-up study on this specific issue [41]. Moreover, it is
well known that the association with DS may sometimes
condition a particularly severe clinical expression of auto-
immunity [51].
Influence of the genes affected by TS and DS
There are at least ten genes located on the X-chromosome
which are known to be possibly involved in the immunere-
gulation process [28]. The most important one is FOXP3,
that encodes a transcription factor for the function of regu-
latory T-cells. Its deletion causes immunodysregulation,
polyendocrinopathy and X-linked enteropathy [28]. Poly-
morphisms of this gene are associated with AITDs in
Caucasian people [52], thus suggesting that FOXP3 hap-
loinsufficiency might be responsible for the increased risk
of AITDs in TS girls [28].
In DS the predisposition to autoimmunity may result
from a partial central tolerance failure due to insufficient
intrathymic expression of AIRE gene, which is located on
chromosome 21 [53]. According to this view, the thymus ofns at Hashimoto’s thyroiditis (HT) presentation in the pediatric
wn syndrome (DS), according to our data
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gene, which may in turn condition the predisposition to
autoimmunity that is typical of DS [53].
Conclusions
The association with TS or DS is able to affect both epi-
demiology and course of AITDs by conditioning: a) an in-
creased susceptibility to these disorders; b) a more frequent
shifting from HT to GD; c) a less severe biochemical pres-
entation and a more severe evolutive pattern of HT in TS
girls; d) a more severe biochemical presentation and evolu-
tion of HT in DS patients.
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